CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,000 | -85.7% | 7,400 | -54.9% | 0.00% | – |
Q3 2018 | $7,000 | +600.0% | 16,400 | +4000.0% | 0.00% | – |
Q2 2018 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 400 | -2.4% | 0.00% | – |
Q2 2017 | $1,000 | -80.0% | 410 | -67.8% | 0.00% | – |
Q1 2017 | $5,000 | +150.0% | 1,273 | +89.2% | 0.00% | – |
Q4 2016 | $2,000 | -50.0% | 673 | -35.8% | 0.00% | – |
Q3 2016 | $4,000 | 0.0% | 1,048 | +23.6% | 0.00% | – |
Q2 2016 | $4,000 | -20.0% | 848 | -35.7% | 0.00% | – |
Q1 2016 | $5,000 | -79.2% | 1,318 | -15.7% | 0.00% | – |
Q4 2015 | $24,000 | +20.0% | 1,563 | -16.1% | 0.00% | – |
Q3 2015 | $20,000 | -39.4% | 1,863 | +44.6% | 0.00% | -100.0% |
Q2 2015 | $33,000 | +37.5% | 1,288 | +45.0% | 0.00% | – |
Q1 2015 | $24,000 | 0.0% | 888 | -32.5% | 0.00% | -100.0% |
Q4 2014 | $24,000 | +2300.0% | 1,315 | +1043.5% | 0.00% | – |
Q3 2014 | $1,000 | -98.0% | 115 | -96.3% | 0.00% | -100.0% |
Q2 2014 | $50,000 | +35.1% | 3,070 | +46.2% | 0.00% | 0.0% |
Q1 2014 | $37,000 | -19.6% | 2,100 | +10.5% | 0.00% | 0.0% |
Q4 2013 | $46,000 | -89.6% | 1,900 | -84.7% | 0.00% | -93.3% |
Q3 2013 | $441,000 | +141.0% | 12,450 | +6.0% | 0.02% | +114.3% |
Q2 2013 | $183,000 | – | 11,750 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Byrne Asset Management LLC | 86 | $2,000 | 0.00% |